Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients- Parametric Survival Modelling
Abstract
Authors
E. Soini M. Holmberg C. Asseburg M.L. Sumelahti